We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
-10.89%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$754M
AUM Growth
-$97.5M
(-11%)
Cap. Flow
+$8.85M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
34.4%
Holding
222
New
21
Increased
61
Reduced
89
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$1.65M |
| 2 |
Teladoc Health
TDOC
|
+$1.6M |
| 3 |
Merck
MRK
|
+$1.47M |
| 4 |
Amalgamated Financial
AMAL
|
+$1.45M |
| 5 |
Nike
NKE
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.89M |
| 2 |
IBM
IBM
|
+$2.63M |
| 3 |
J.M. Smucker
SJM
|
+$2.51M |
| 4 |
Gilead Sciences
GILD
|
+$1.28M |
| 5 |
COL
Rockwell Collins
COL
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.69% |
| 2 | Technology | 17.94% |
| 3 | Industrials | 12.44% |
| 4 | Financials | 11.62% |
| 5 | Communication Services | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
126
DELISTED
bluebird bio
BLUE
| $504K | 0.07% |
392
-133
| -25% | -$204K |
|
127
Regeneron Pharmaceuticals
REGN
$82.1B
| $499K | 0.07% |
+1,335
| New | +$489K |
|
128
Autoliv
ALV
$8.96B
| $497K | 0.07% |
7,078
-2,320
| -25% | -$188K |
|
129
Corning
GLW
$137B
| $485K | 0.06% |
+16,057
| New | +$512K |
|
130
Sysco
SYY
$40.3B
| $458K | 0.06% |
7,305
| – | – |
|
131
Qualcomm
QCOM
$171B
| $449K | 0.06% |
7,897
-1,280
| -14% | -$77.7K |
|
132
Palo Alto Networks
PANW
$313B
| $443K | 0.06% |
+14,100
| New | +$440K |
|
133
iShares Russell 1000 Growth ETF
IWF
$127B
| $428K | 0.06% |
13,084
+1,548
| +13% | +$54.6K |
|
134
Nexstar Media Group
NXST
$5.69B
| $417K | 0.06% |
+5,300
| New | +$419K |
|
135
Telephone and Data Systems
TDS
$3.84B
| $417K | 0.06% |
+12,800
| New | +$425K |
|
136
Vanguard Morningstar Growth ETF
VUG
$228B
| $414K | 0.05% |
18,504
-810
| -4% | -$19.6K |
|
137
Enterprise Products Partners
EPD
$81.8B
| $410K | 0.05% |
16,663
+667
| +4% | +$17.9K |
|
138
Cigna
CI
$72.4B
| $396K | 0.05% |
2,086
+721
| +53% | +$150K |
|
|
SGEN
139
DELISTED
Seagen Inc. Common Stock
SGEN
| $385K | 0.05% |
+6,800
| New | +$426K |
|
140
iShares S&P 500 Value ETF
IVE
$50B
| $374K | 0.05% |
3,697
| – | – |
|
141
Comcast
CMCSA
$91B
| $373K | 0.05% |
10,968
+4,400
| +67% | +$161K |
|
142
SLB Ltd
SLB
$79.7B
| $373K | 0.05% |
10,351
-2,092
| -17% | -$103K |
|
143
Adobe
ADBE
$105B
| $370K | 0.05% |
1,635
-50
| -3% | -$12.1K |
|
144
Air Products & Chemicals
APD
$68.9B
| $369K | 0.05% |
2,305
+50
| +2% | +$7.92K |
|
145
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $365K | 0.05% |
1,207
+19
| +2% | +$6.33K |
|
146
UnitedHealth
UNH
$361B
| $364K | 0.05% |
1,460
+105
| +8% | +$27.7K |
|
|
KSU
147
DELISTED
Kansas City Southern
KSU
| $363K | 0.05% |
3,800
| – | – |
|
148
Illinois Tool Works
ITW
$83.5B
| $360K | 0.05% |
2,842
-700
| -20% | -$92.2K |
|
149
Cognizant
CTSH
$26.4B
| $357K | 0.05% |
5,629
-430
| -7% | -$29.9K |
|
150
American Express
AXP
$230B
| $354K | 0.05% |
3,710
-65
| -2% | -$6.8K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Reynders McVeigh Capital Management held 222 positions worth $754M, down 11% from $851M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Reynders McVeigh Capital Management's Q4 2018 filing shows 21 new, 61 increased, 89 reduced and 16 closed positions. Its largest new stake was T-Mobile US: 12,000 shares worth $763K. The largest sale was Celgene Corp, an estimated $2.89M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q4 2018 buy was T-Mobile US: 12,000 shares worth $763K.
- Reynders McVeigh Capital Management added most to New York Times in Q4 2018, an estimated $1.65M increase.
- Reynders McVeigh Capital Management's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $2.89M.
- Reynders McVeigh Capital Management fully exited Rockwell Collins in Q4 2018, selling an estimated $1.23M.
- Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $754M portfolio in Q4 2018.
- Reynders McVeigh Capital Management opened 21 new positions and closed 16 in Q4 2018.
- Reynders McVeigh Capital Management's portfolio value fell 11% quarter-over-quarter to $754M.
Based on Reynders McVeigh Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.